• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Comparative Analysis of Modified BT Shunt and Central Shunt in Pediatric Patients.改良 BT 分流术与中心静脉分流术在小儿患者中的对比分析。
Braz J Cardiovasc Surg. 2024 May 15;39(3):e20230376. doi: 10.21470/1678-9741-2023-0376.
2
Inotropes for the prevention of low cardiac output syndrome and mortality for paediatric patients undergoing surgery for congenital heart disease: a network meta-analysis.正性肌力药物预防先天性心脏病患儿心脏手术低心排血量综合征和死亡率的效果:网状 Meta 分析。
Cochrane Database Syst Rev. 2024 Nov 26;11(11):CD013707. doi: 10.1002/14651858.CD013707.pub2.
3
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
4
Interventions for infantile haemangiomas of the skin.皮肤婴儿血管瘤的干预措施。
Cochrane Database Syst Rev. 2018 Apr 18;4(4):CD006545. doi: 10.1002/14651858.CD006545.pub3.
5
Nutritional interventions for survivors of childhood cancer.儿童癌症幸存者的营养干预措施。
Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD009678. doi: 10.1002/14651858.CD009678.pub2.
6
Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.布洛芬用于治疗早产和/或低出生体重婴儿的动脉导管未闭。
Cochrane Database Syst Rev. 2008 Jan 23(1):CD003481. doi: 10.1002/14651858.CD003481.pub3.
7
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
8
Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease.预防性使用左西孟旦预防先天性心脏病手术患儿的低心排血量综合征和死亡率。
Cochrane Database Syst Rev. 2017 Aug 2;8(8):CD011312. doi: 10.1002/14651858.CD011312.pub3.
9
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
10
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.用于治疗符合抗逆转录病毒治疗条件的孕妇艾滋病毒感染的抗逆转录病毒疗法。
Cochrane Database Syst Rev. 2010 Mar 17(3):CD008440. doi: 10.1002/14651858.CD008440.

引用本文的文献

1
Restrictive Atrial Communication in Tricuspid Atresia With Minimal Duct-Dependent Pulmonary Circulation in a Newborn.新生儿三尖瓣闭锁合并最小程度依赖动脉导管的肺循环中的限制性心房交通
JACC Case Rep. 2025 May 28;30(12):103515. doi: 10.1016/j.jaccas.2025.103515. Epub 2025 Apr 23.

本文引用的文献

1
Revisiting the central aortopulmonary shunt procedure.重新审视中心性主肺动脉分流术。
Turk Gogus Kalp Damar Cerrahisi Derg. 2023 Apr 28;31(2):207-214. doi: 10.5606/tgkdc.dergisi.2023.24247. eCollection 2023 Apr.
2
Patent Ductus Arteriosus Stenting for All Ductal-Dependent Cyanotic Infants: Waning Use of Blalock-Taussig Shunts.动脉导管未闭支架置入术治疗所有依赖动脉导管生存的发绀型婴儿:Blalock-Taussig 分流术使用减少。
Circ Cardiovasc Interv. 2021 Mar;14(3):e009520. doi: 10.1161/CIRCINTERVENTIONS.120.009520. Epub 2021 Mar 9.
3
Predictors of death after receiving a modified Blalock-Taussig shunt in cyanotic heart children: A competing risk analysis.紫绀型先天性心脏病患儿行改良 Blalock-Taussig 分流术后死亡的预测因素:竞争风险分析。
PLoS One. 2021 Jan 22;16(1):e0245754. doi: 10.1371/journal.pone.0245754. eCollection 2021.
4
Transcatheter ductus arteriosus stenting in paediatric cardiology: Indications, results and perspectives.经导管动脉导管未闭封堵术在儿科心脏病学中的应用:适应证、结果与展望。
Arch Cardiovasc Dis. 2020 Feb;113(2):129-141. doi: 10.1016/j.acvd.2019.10.004. Epub 2019 Nov 18.
5
Blalock-Taussig Shunt Size: Should it be Based on Body Weight or Target Branch Pulmonary Artery Size?布莱洛克-陶西格分流术的尺寸:应基于体重还是目标分支肺动脉的尺寸?
Pediatr Cardiol. 2019 Jan;40(1):38-44. doi: 10.1007/s00246-018-1958-9. Epub 2018 Aug 18.
6
Risk factors for in-hospital shunt thrombosis and mortality in patients weighing less than 3 kg with functionally univentricular heart undergoing a modified Blalock-Taussig shunt.体重小于3千克且功能单心室心脏的患者行改良布莱洛克-陶西格分流术时发生院内分流血栓形成及死亡的危险因素。
Interact Cardiovasc Thorac Surg. 2017 Sep 1;25(3):407-413. doi: 10.1093/icvts/ivx147.
7
Modified Blalock-Taussig shunt: simple but unpredictable.改良布莱洛克-陶西格分流术:操作简单但效果难以预测。
Eur J Cardiothorac Surg. 2016 Jul;50(1):178-9. doi: 10.1093/ejcts/ezw115. Epub 2016 Mar 31.
8
Factors affecting death and progression towards next stage following modified Blalock-Taussig shunt in neonates.影响新生儿改良布莱洛克-陶西格分流术后死亡及进入下一阶段进展的因素。
Eur J Cardiothorac Surg. 2016 Jul;50(1):169-77. doi: 10.1093/ejcts/ezw017. Epub 2016 Feb 23.
9
Optimal Graft Size of Modified Blalock-Taussig Shunt for Biventricular Circulation in Neonates and Small Infants.新生儿和小婴儿双心室循环改良布莱洛克-陶西格分流术的最佳移植物尺寸
Int Heart J. 2015;56(5):533-6. doi: 10.1536/ihj.15-042. Epub 2015 Sep 11.
10
Disease-specific outcome analysis of palliation with the modified Blalock-Taussig shunt.改良布莱洛克-陶西格分流术姑息治疗的疾病特异性结局分析
World J Pediatr Congenit Heart Surg. 2015 Jan;6(1):67-74. doi: 10.1177/2150135114558690.

改良 BT 分流术与中心静脉分流术在小儿患者中的对比分析。

Comparative Analysis of Modified BT Shunt and Central Shunt in Pediatric Patients.

机构信息

Department of Pediatric Cardiovascular Surgery, Ankara Bilkent City Hospital, Ankara, Turkey.

0000-0002-3212-2673.

出版信息

Braz J Cardiovasc Surg. 2024 May 15;39(3):e20230376. doi: 10.21470/1678-9741-2023-0376.

DOI:10.21470/1678-9741-2023-0376
PMID:38748885
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11099994/
Abstract

INTRODUCTION

Cyanotic congenital heart diseases constitute 40-45% of all congenital heart diseases. In patients who are not suitable for primary repair, modified BT (MBT) shunt and central shunt (CS) procedures are still frequently used.

METHODS

This study included 62 pediatric patients who underwent MBT shunt or CS via median sternotomy. Patients' demographic, echocardiographic, operative, and postoperative data were collected retrospectively. The patients were classified as single ventricle and bi-ventricle according to their cardiac anatomy, and the presence of prematurity and heterotaxy was noted. Procedure details of the patients who underwent endovascular intervention prior to the surgery were investigated, and operation data were accessed from the surgery notes. Data regarding postoperative follow-ups were obtained and comparatively analyzed.

RESULTS

Of the total 62 patients, 32 (51.6%) were newborns and 16 (25.8%) had a body weight < 3 kg. MBT shunt was applied to 48 patients (77.4%), while CS was applied to 14 patients (22.6%). There was no significant difference between the two surgical procedures in terms of requirement for urgent shunt or cardiopulmonary bypass, additional simultaneous surgical intervention, need for high postoperative inotropes, and in-hospital mortality (P>0.05). The rate of congestive heart failure in patients with in-hospital mortality was determined as 66.7% and it was significantly higher than in patients without heart failure (P<0.001).

CONCLUSION

MBT shunt and CS are still frequently used in cyanotic patients. The use of small-diameter shunts, particularly when centrally located, can prevent the onset of congestive heart failure and lower mortality.

摘要

介绍

青紫型先天性心脏病占所有先天性心脏病的 40-45%。对于不适合一期修复的患者,改良 Blalock-Taussig(MBT)分流和中央分流(CS)仍然经常使用。

方法

本研究纳入了 62 例行正中开胸 MBT 分流或 CS 的儿科患者。回顾性收集患者的人口统计学、超声心动图、手术和术后数据。根据心脏解剖结构将患者分为单心室和双心室,并记录早产儿和内脏异位的存在情况。研究了手术前接受血管内介入治疗的患者的介入程序细节,并从手术记录中获取了手术数据。获取了术后随访数据并进行了比较分析。

结果

在 62 例患者中,32 例(51.6%)为新生儿,16 例(25.8%)体重<3kg。48 例(77.4%)采用 MBT 分流,14 例(22.6%)采用 CS。两种手术在需要紧急分流或体外循环、附加同期手术干预、需要高术后正性肌力药物和院内死亡率方面无显著差异(P>0.05)。院内死亡患者充血性心力衰竭发生率为 66.7%,显著高于无心力衰竭患者(P<0.001)。

结论

MBT 分流和 CS 仍常用于青紫型患者。使用小直径分流管,特别是中央分流管,可以预防充血性心力衰竭的发生并降低死亡率。